Drug General Information
Drug ID	D01IGL
Former ID	DNC009201
Drug Name	(+/-)-3-allyl-1-pent-4-enoylazetidin-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529529]
Structure		Download 2D MOL 3D MOL
Formula	C11H15NO2
Canonical SMILES	C=CCCC(=O)N1CC(C1=O)CC=C
InChI	1S/C11H15NO2/c1-3-5-7-10(13)12-8-9(6-4-2)11(12)14/h3-4,9H,1-2,5-8H2
InChIKey	QVTWEMBUZOBMIJ-UHFFFAOYSA-N
PubChem Compound ID	44560665
Target and Pathway
Target(s)	Fatty-acid amide hydrolase	Target Info	Inhibitor	[529529]
BioCyc Pathway	Anandamide degradation
KEGG Pathway	Retrograde endocannabinoid signaling
PANTHER Pathway	Anandamide degradation
References
Ref 529529	Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Ref 529529	Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.